Nance Mark E
SEC CIK 1755882 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVST | Envista Holdings Corp | GC | 81.3K | $108.8K | $259.9K | 21 | 2021-07-15 | 2026-02-25 |
Most active insiders at NVST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reis Mischa | SVP, Strategy, Bus. Dev | — | $510.2K |
| 2 | Acurio Veronica | Pres, Orthodontics | — | — |
| 3 | Nilsson Stefan | Pres, Nobel Biocare | — | — |
| 4 | Befidi Robert | Pres, Diagnostics | — | — |
| 5 | Kaabi Faez C | CAO | — | — |
| 6 | Pierce James Andrew | Dir | — | — |
| 7 | Nance Mark E | GC | — | — |
| 8 | Keel Paul A | CEO, Dir | — | — |
| 9 | Hammes Eric D. | CFO | — | — |
| 10 | Carruthers Wendy | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-27 | 2026-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | A - Grant | $0.00 | +12.7K | 81.3K | +18% | $0 |
| D | 2026-02-27 | 2026-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $29.59 | -3,368 | 68.6K | -5% | -$99.7K |
| D | 2025-02-27 | 2025-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | A - Grant | $0.00 | +18.2K | 71.9K | +34% | $0 |
| D | 2025-02-27 | 2025-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $20.66 | -3,691 | 53.8K | -6% | -$76.3K |
| 2024-07-17 | 2024-07-15 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $15.94 | -491 | 57.5K | -0.8% | -$7,827 | |
| D | 2024-02-27 | 2024-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $22.65 | -2,600 | 36.4K | -7% | -$58.9K |
| D | 2024-02-27 | 2024-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | A - Grant | $0.00 | +21.5K | 58.0K | +59% | $0 |
| 2023-11-09 | 2023-11-08 | NVST | Envista Holdings Corp | Nance Mark E | GC | P - Purchase | $21.75 | +5,000 | 39.0K | +15% | +$108.8K | |
| 2023-07-17 | 2023-07-15 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $35.07 | -492 | 34.0K | -1% | -$17.3K | |
| D | 2023-02-28 | 2023-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $38.25 | -2,021 | 28.3K | -7% | -$77.3K |
| D | 2023-02-28 | 2023-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | A - Grant | $0.00 | +6,210 | 34.5K | +22% | $0 |
| 2022-07-19 | 2022-07-15 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $38.79 | -540 | 30.3K | -2% | -$20.9K | |
| D | 2022-03-01 | 2022-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $48.52 | -1,637 | 26.2K | -6% | -$79.4K |
| D | 2022-03-01 | 2022-02-25 | NVST | Envista Holdings Corp | Nance Mark E | GC | A - Grant | $0.00 | +4,640 | 30.9K | +18% | $0 |
| DM | 2021-09-16 | 2021-09-14 | NVST | Envista Holdings Corp | Nance Mark E | GC | S - Sale+OE | $44.01 | -4,321 | 30.7K | -12% | -$190.1K |
| D | 2021-09-16 | 2021-09-14 | NVST | Envista Holdings Corp | Nance Mark E | GC | M - OptEx | $27.05 | +4,321 | 32.2K | +15% | +$116.9K |
| DM | 2021-09-07 | 2021-09-02 | NVST | Envista Holdings Corp | Nance Mark E | GC | S - Sale+OE | $43.99 | -980 | 27.9K | -3% | -$43.1K |
| D | 2021-09-07 | 2021-09-02 | NVST | Envista Holdings Corp | Nance Mark E | GC | M - OptEx | $27.05 | +980 | 28.9K | +4% | +$26.5K |
| DM | 2021-08-04 | 2021-08-02+ | NVST | Envista Holdings Corp | Nance Mark E | GC | M - OptEx | $27.05 | +604 | 28.2K | +2% | +$16.3K |
| DM | 2021-08-04 | 2021-08-02+ | NVST | Envista Holdings Corp | Nance Mark E | GC | S - Sale+OE | $44.07 | -604 | 27.9K | -2% | -$26.6K |
| 2021-07-16 | 2021-07-15 | NVST | Envista Holdings Corp | Nance Mark E | GC | F - Tax | $41.91 | -540 | 27.9K | -2% | -$22.6K |
Purchase Sale Sale after option exercise All abbreviations